Skip to main content
. 2018 May 18;12:861–868. doi: 10.2147/PPA.S162744

Table 3.

Scoring of the symptoms during the 12-week treatment

Time Symptom score Conventional nebulization N (%) Smart nebulization N (%) Total N (%) P-value
Day-time during the 1st week 0 3 (8.57) 1 (3.33) 4 (6.15) 0.911
1 15 (42.86) 14 (46.67) 29 (44.62)
2 14 (40.00) 15 (50.00) 29 (44.62)
3 3 (8.57) 0 (0.00) 3 (4.62)
Night-time during the 1st week 0 8 (22.86) 7 (23.33) 15 (23.08) 0.865
1 14 (40.00) 10 (33.33) 24 (36.92)
2 10 (28.57) 11 (36.67) 21 (32.31)
3 3 (8.57) 2 (6.67) 5 (7.69)
Day-time during the 4th week 0 9 (25.71) 14 (46.67) 23 (35.38) 0.032
1 9 (25.71) 8 (26.67) 17 (26.15)
2 12 (34.29) 7 (23.33) 19 (29.23)
3 5 (14.29) 1 (3.33) 6 (9.23)
Night-time during the 4th week 0 10 (28.57) 15 (50.00) 25 (38.46) 0.037
1 12 (34.29) 9 (30.00) 21 (32.31)
2 10 (28.57) 6 (20.00) 16 (24.62)
3 3 (8.57) 0 (0.00) 3 (4.62)
Day-time during the 8th week 0 9 (25.71) 17 (56.67) 26 (40.00) 0.030
1 11 (31.43) 5 (16.67) 16 (24.62)
2 9 (25.71) 6 (20.00) 15 (23.08)
3 6 (17.14) 2 (6.67) 8 (12.31)
Night-time during the 8th week 0 11 (31.43) 16 (53.33) 27 (41.54) 0.046
1 11 (31.43) 10 (33.33) 21 (32.31)
2 10 (28.57) 2 (6.67) 12 (18.46)
3 3 (8.57) 2 (6.67) 5 (7.69)
Day-time during the 12th week 0 15 (42.86) 18 (60.00) 33 (50.77) 0.031
1 5 (14.29) 7 (23.33) 12 (18.46)
2 6 (17.14) 3 (10.00) 9 (13.85)
3 9 (25.71) 2 (6.67) 11 (16.92)
Night-time during the 12th week 0 15 (42.86) 19 (63.33) 34 (52.31) 0.044
1 7 (20.00) 6 (20.00) 13 (20.00)
2 8 (22.86) 4 (13.33) 12 (18.46)
3 5 (14.29) 1 (3.33) 6 (9.23)